You Searched For "blue jet healthcare ipo" and got 20 results
Sort By:
1 min read
Blue Jet Healthcare eyes Rs 840 cr via IPO; sets price band at Rs 329-346 per share
Pharmaceutical ingredient maker Blue Jet Healthcare on Thursday fixed a price band of Rs 329-346 pe…
PTI
3 mins read
Blue Jet Healthcare closes debut session with 14.4% listing gains
The stock of pharma intermediates manufacturer Blue Jet Healthcare debuted at 4% premium on the bou…
3 mins read
Blue Jet Healthcare’s initial public offer subscribed 7.9x
The initial public offer (IPO) of pharma intermediates manufacturer Blue Jet Healthcare was subscri…
2 mins read
Blue Jet allotment – How to check allotment, GMP, listing date and more
Mumbai -based Blue Jet Healthcare, a pharmaceutical and healthcare ingredient and an intermediate c…
2 mins read
Indegene's ₹1,842 crore IPO to open on May 6
The company's IPO comprises a fresh issue of equity shares worth up to Rs 760 crore and an Offe…
PTI
1 min read
Innova Captab, Blue Jet Healthcare get Sebi's nod to float IPO
Pharmaceutical companies Innova Captab Ltd and Blue Jet Healthcare have received Sebi's go-ahead to…
PTI
3 mins read
Cello World stock closes 22% higher than issue price on debut day
Cello World debuted on the stock exchanges with a 28% premium on Monday, overshooting grey market e…
3 mins read
Protean eGov Technologies closes debut day with 11% listing gains
Protean eGov Technologies listed at 3% premium on Monday on the first day of Samvat 2080. The grey …
3 mins read
ESAF Small Finance Bank lists at 20% premium but below grey market expectations
ESAF Small Finance Bank made its D-street debut at a 20% premium on Friday. This is lower than what…
3 mins read
Mamaearth parent, Honasa Consumer gives 4% listing gains on debut day
Mamaearth’s parent Honasa Consumer made its D-street debut at a 3% premium on Tuesday morning. The …
3 mins read
The digital health startups that are ripe for an IPO
These are Business Insider's biggest healthcare stories for November 2.
Megan Hernbroth
4 mins read
A top IPO banker in Moscow fears it will be decades before he sees another listing: 'We're in a new world'
"Nobody knows what the fuck is happening," he said. "All I know for certain is that it won't be for…
Jason Corcoran
2 mins read
Warren Buffett's great-nephew just completed a SPAC deal. He clearly shares the billionaire investor's taste in businesses.
Alex Buffett Rozek and his great-uncle look for similar things in businesses, including competitive…
Theron Mohamed
3 mins read
Jeff Bezos thanked Amazon workers for paying for his space flight. For some, the feeling isn't mutual.
Bezos thanked Amazon employees and customers after his Blue Origin flight, saying "you guys paid fo…
Tyler Sonnemaker,Aleeya Mayo,…
6 mins read
Jeff Bezos just launched to the edge of space. Here's how Blue Origin's plans stack up to SpaceX and Virgin Galactic.
Bezos envisions a moon base, while Musk dreams of a Mars colony. Branson's Virgin Galactic may make…
Tim Levin
6 mins read
The rise of Anne Wojcicki, the CEO of 23andMe who's about to be worth more than $1 billion when the genetic-testing giant makes its public debut
With Wojcicki gearing up to take 23andMe public, here's a look back at how she got her start and bu…
Avery Hartmans
4 mins read
CULTIVATED: Inside the rise and fall of Civilized — An uphill battle for Black cannabis entrepreneurs — Legal cannabis and coronavirus
In this edition, we bring you inside the rise and fall of cannabis media company Civilized, and mor…
Jeremy Berke
2 mins read
C3.ai shares rocket 6% as meteoric post-IPO run continues
CEO Tom Siebel told CNBC on Friday that there is a clean energy future for AI, as shares of the com…
Will Daniel
5 mins read
The future of finance, inside Peloton's IPO, and CMOs to watch
Take Thasos Group. A player in the booming $7 billion alternative-data industry, Thasos was worth $…
Matt Turner
7 mins read
Uber and Lyft's IPOs will trigger competition at Google; hedge funds cut stock-pickers; hot marijuana IPOs
I went down a bit of a rabbit hole this week after reading our reporter Dan DeFrancesco's piece abo…